Sharda Cropchem Ltd. · NSE:SHARDACROP

Sharda Cropchem — Q1 FY27 Earnings Presentation

23 slides from Sharda Cropchem's earnings presentation, Jul 29, 2026

  1. Slide 1: Stock exchange filing cover letter

    29th July, 2026 To, National Stock Exchange of India BSE Limited Limited Phiroze Jeejeebhoi Tower, Exchange Plaza, 5th Floor, Plot No. Dalal Street, C/1, Mumbai – 400 001 G-Block, Bandra Kurla Complex, Bandra (E), Mumbai – 400 051 Trading Symbol: SHARDACROP Scrip Code: 538666 Subject: Investors / An

  2. Slide 2: Investor Presentation - Steady. Strong. Growing.

    STEADY. STRONG. GROWING. Investor Presentation 1 July 2026

  3. Slide 3: Safe Harbor

    Safe Harbor This presentation has been prepared by and is the sole responsibility of Sharda Cropchem Limited (the “Company”). By accessing this presentation, you are agreeing to be bound by the trailing restrictions. This presentation does not constitute or form part of any offer or invitation or in

  4. Slide 4: Advancing Global Agriculture Through an IP-Led Growth Platform

    ADVANCING GLOBAL AGRICULTURE THROUGH AN IP-LED GROWTH PLATFORM Sharda Cropchem Limited is a leading intellectual property-driven agrochemical company engaged in the marketing and distribution of crop protection formulations and generic active ingredients. Supported by a growing portfolio of dossiers

  5. Slide 5: Creating Value Through an Asset-Light, Registration-Led Business Model

    CREATING VALUE THROUGH AN At the core of SCL business model is a growing portfolio of regulatory assets that facilitates access to some of the world’s most attractive crop protection markets. By partnering with specialized manufacturers for active ingredients, formulation and packaging, we remain ca

  6. Slide 6: Creating Value Across the Chain

    CREATING VALUE ACROSS THE CHAIN Identifying Building Regulatory Leveraging a Flexible Commercializing Opportunities Ahead Assets through Supply Network Products at Global of the Market Dossier Development Scale We source active ingredients Continuously monitor patent Working with accredited through

  7. Slide 7: Ensuring Reach That Serves Globally

    ENSURING REACH THAT SERVES 80+ Countries GLOBALLY SCL’s extensive global presence is complemented by a well-established 525+ network of third-party distributors. Supported by a network of Together, these capabilities enable Distributors the effective commercialisation of distributors and sales formu

  8. Slide 8: Two Business Segments, One Platform

    Two Business Segments, One Platform AGROCHEMICALS AGROCHEMICALS NON - AGROCHEMICAL Crop protection solutions that help improve yields and safeguard agricultural Leverages the same sourcing, logistics and distribution productivity across global markets. Agrochemicals remain our core business capabili

  9. Slide 9: Building the Next Phase

    Building the Next Phase Building on a period of strong progress, SCL is strengthening its platform for sustainable growth and long-term value creation — centred on regulatory expertise, market access, portfolio depth and customer proximity, while maintaining financial discipline and operational exce

  10. Slide 10: The Sharda Advantage: A Differentiated Business Model

    The Sharda Advantage: A Differentiated Business Model IP-led Growth Asset-Light Diversified Sourcing Global Presence Extensive Model Operations Network Distribution Reach IP-led Growth Model Strong portfolio of Capital-efficient Strong relationships Operations spanning Widespread network registratio

  11. Slide 11: Experienced Management

    Experienced Management Mr. Ramprakash V. Bubna Mr. Ashish Bubna Mr. Manish Bubna Chairman & Managing Director Whole Time Director Whole Time Director ✓ Holds a Bachelor’s Degree of Technology in Chemical ✓ Holds a Bachelor’s Degree in Commerce from the ✓ Holds a Bachelor’s Degree in Chemical Enginee

  12. Slide 12: Q1 FY27 Financial Highlights

    Q1 FY27 Financial Highlights 11

  13. Slide 13: Q1 FY27 Financial Highlights - Product Wise

    Q1 FY27 Financial Highlights Revenue Revenue Total Revenue Agro-chemical Segment (A) Non Agro-chemical Segment (B) (A+B) Rs. 915 Crs. Rs. 159 Crs. Rs. 1,074 Crs. (+8% YoY) (+15% YoY) (+9% YoY) Gross Profit EBITDA EBITDA Margin Profit Before Tax (PBT)* (excl. Forex gains) Rs. 394 Crs. Rs. 178 Crs. 16

  14. Slide 14: Q1 FY27 Financial Highlights (Region Wise Breakup)

    Q1 FY27 Financial Highlights (Region Wise Breakup) Europe NAFTA LATAM ROW Agro Rs. 467 Crs. Rs. 339 Crs. Rs. 72 Crs. Rs. 37 Crs. (-11% YoY) (+33% YoY) (+52% YoY) (+78% YoY) Europe NAFTA LATAM ROW Non – Agro Rs. 19 Crs. Rs. 121 Crs. Rs. 5 Crs. Rs. 14 Crs. (-12% YoY) (+31% YoY) (-60% YoY) (+9% YoY) ST

  15. Slide 15: Q1 FY27 Financial Highlights

    Q1 FY27 Financial Highlights Particulars Q1 FY27 Q1 FY26 Y-o-Y Revenue from Operations 1,073.8 984.8 9% COGS 679.8 635.6 Gross Profit 394.0 349.2 13% Gross Margin % 36.7% 35.5% 120 bps Employee Expenses 17.7 14.9 Other Expenses 197.9 192.1 EBITDA* 178.4 142.2 25% EBITDA Margin % 16.6% 14.4% 220 bps

  16. Slide 16: Strong Balance Sheet

    Strong Balance Sheet TOTAL EQUITY ^ CASH, BANK & LIQUID INVESTMENTS ^ RETURNS* Rs. 3,245 Crs. Rs. 767 Crs. 30.4% 24.2% vs Rs. 3,137 Crs. as on Mar’26 vs Rs. 702 Crs. as on Mar’26 RoCE RoE WORKING CAPITAL (IN DAYS) Inventory Days Recievable Days Creditor Days 98 → 88 days 151 125 110 103 Mar26 June’2

  17. Slide 17: Annexure

    Annexure 16

  18. Slide 18: Key Financial Performance Indices

    Key Financial Performance Indices Cr. Revenue EBITDA & EBITDA Margin* Profit After Tax & PAT Margin 20.4% 17.6% 10.1% 14.2% 19.7% 9.8% 8.5% 1.0% 7.0% 12.9% 5,268 4,045 4,320 3,580 1,040 681 3,163 729 713 613 349 342 304 318 32 FY22 FY23 FY24 FY25 FY26 FY22 FY23 FY24 FY25 FY26 FY22 FY23 FY24 FY25 FY2

  19. Slide 19: Historical Profit & Loss

    Historical Profit & Loss Cr. Particulars FY26 FY25 FY24 FY23 FY22 Revenue from Operations 5,267.6 4,319.9 3,163.0 4,045.2 3,579.8 COGS 3,377.2 3,028.1 2,342.4 2,860.8 2,499.8 Gross Profit 1,890.4 1,291.8 820.6 1,184.4 1,080.0 Gross Margin % 35.9% 29.9% 25.9% 29.3% 30.2% Employee Expenses 66.7 52.0 4

  20. Slide 20: Balance Sheet – Equity & Liabilities

    Balance Sheet – Equity & Liabilities Cr. Equities & Liabilities Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Shareholder's Funds Equity and Share Capital 90.2 90.2 90.2 90.2 90.2 Other Equity 3,046.3 2,410.3 2,146.9 2,141.8 1,822.2 Non-controlling Interest 0.5 0.4 0.4 0.4 0.3 Total Equity 3,137.0 2,501.0 2,23

  21. Slide 21: Balance Sheet – Assets

    Balance Sheet – Assets Cr. ASSETS Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Assets Non-Current Assets Property, Plant and Equipment 2.5 3.0 3.8 5.0 14.4 Right to Use Assets 0.0 7.2 14.4 0.0 - Goodwill 0.0 0.0 0.0 0.0 0.0 Other Intangible assets 986.2 740.2 690.0 663.0 577.4 Intangible assets under developm

  22. Slide 22: Cash Flow Statement

    Cash Flow Statement Cr. Particulars Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Profit Before Tax 855.5 378.3 71.9 430.7 464.2 Adjustments 319.1 286.8 272.8 266.5 256.9 Operating profit before working capital changes 1,174.6 665.1 344.6 697.2 721.1 Changes in working capital (453.9) (30.5) 47.0 (303.7) (379.

  23. Slide 23: Thank You

    STEADY. STRONG. GROWING. THANK YOU Company: Sharda Cropchem Limited Investor Relation Advisors: Strategic Growth Advisors Pvt. Ltd. CIN: L51909MH2004PLC145007 CIN: U74140MH2010PTC204285 Mr. Shailesh Mehendale – CFO Mr. Deven Dhruva / Mr. Ronak Jain cfo@shardaintl.com / finance@shardaintl.com deven.d

Sharda Cropchem — Q1 FY27 Earnings Presentation on 6ix